Ascentage Pharma Group Intl ADR (AAPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AAPG | AZN | AMGN | GILD | GSK |
| Company | Ascentage Pharma Group Intl ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 22.83 | 183.93 | 335.01 | 128.90 | 50.00 |
| High | 22.83 | 187.00 | 339.12 | 129.96 | 52.13 |
| Low | 22.20 | 181.73 | 333.55 | 128.00 | 49.99 |
| Latest | 22.48 | 185.20 | 338.02 | 128.84 | 51.40 |
| Change | -0.52 | -1.48 | -1.55 | -0.42 | -3.07 |
| % Change | -2.26% | -0.79% | -0.46% | -0.32% | -5.64% |
| Volume | 5,200 | 4,443,000 | 2,516,500 | 5,048,200 | 11,238,500 |
| 20-Day Average Volume | 3,345 | 2,018,020 | 2,402,840 | 5,245,205 | 4,290,555 |
| Previous Close | 23.00 | 186.68 | 339.57 | 129.26 | 54.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.56 | 198.35 | 347.29 | 136.45 | 56.48 |
| 20-Day Raw Stochastic | 4.78% | 13.57% | 17.26% | 7.83% | 14.75% |
| 20-Day Relative Strength | 42.79 | 39.06 | 40.54 | 35.66 | 36.86 |
| Weighted Alpha | -24.81 | +24.04 | +17.59 | +18.69 | +28.20 |
| Today's Opinion | 88% Sell | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Previous Opinion | 80% Sell | 40% Buy | 8% Buy | 8% Buy | 64% Buy |
| Last Month's Opinion | 88% Sell | 72% Buy | 40% Buy | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.55% since 04/22/26 | -4.93% since 04/22/26 | -2.28% since 04/22/26 | -3.05% since 04/22/26 | -7.72% since 04/22/26 |
| Low | 22.20 on 04/29/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 49.99 on 04/29/26 |
| High | 23.95 on 04/24/26 | 196.64 on 04/23/26 | 350.69 on 04/23/26 | 134.68 on 04/23/26 | 56.19 on 04/23/26 |
| 1-Month | |||||
| %Chg | -2.43% since 03/27/26 | -1.71% since 03/27/26 | -3.08% since 03/27/26 | -4.03% since 03/27/26 | -4.53% since 03/27/26 |
| Low | 22.20 on 04/29/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 49.99 on 04/29/26 |
| High | 28.06 on 04/06/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.57 on 04/14/26 |
| 3-Month | |||||
| %Chg | -10.08% since 01/29/26 | +0.01% since 01/29/26 | -1.43% since 01/29/26 | -7.67% since 01/29/26 | +1.46% since 01/29/26 |
| Low | 19.11 on 03/20/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 49.99 on 04/29/26 |
| High | 28.06 on 04/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -32.69% since 10/29/25 | +12.61% since 10/29/25 | +15.85% since 10/29/25 | +8.73% since 10/29/25 | +11.91% since 10/29/25 |
| Low | 19.11 on 03/20/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 45.81 on 11/20/25 |
| High | 34.50 on 11/14/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,146,613 | 289,523,488 | 183,260,832 | 160,440,352 | 110,530,416 |
| Shares Outstanding, K | 93,331 | 1,550,908 | 539,685 | 1,241,222 | 2,029,198 |
| Annual Sales | 82,100,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -177,710,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,424,970,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 851,670,000 |
| 60-Month Beta | 0.79 | 0.35 | 0.47 | 0.39 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.68 on 02/04/26 |
| Earnings Date | 03/25/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.470 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.47 | 15.57 | 15.67 | 12.00 |